Moderna vs ONCOMATRYX
Moderna vs ONCOMATRYX, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moderna is on 77/100 and ONCOMATRYX on 50/100.
Where each one leads
Moderna
- our overall score: 77/100 against 50/100
- agent readiness: 49/100 against 36/100
- domain rating: 79/100 against 26/100
- headcount: 6,297 against 36
- funding raised: $4.5B against $107M
- LinkedIn following: 780,086 against 5,170
ONCOMATRYX
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Moderna | ONCOMATRYX |
|---|---|---|
| What it is | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2010 | 2009 |
| Headquarters | Cambridge, United States | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Moderna | ONCOMATRYX |
|---|---|---|
| Employees | 6,297 | 36 |
| Open roles | 100 | Not published |
| Total funding | $4.5B | $107M |
| Latest round | Funding Round | Funding Round |
| LinkedIn followers | 780,086 | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moderna | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 77/100 | 50/100 |
| Traction | 60/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Community | 13/100 | Not published |
| Search visibility | 46/100 | 37/100 |
| Quality | 90/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 79/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moderna | ONCOMATRYX |
|---|---|---|
| Hosting | AWS | Self Managed |
| CDN | CloudFront | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Next.js | Jquery |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Moderna | ONCOMATRYX |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 2.0/5 from 1 vote | Not published |
Moderna vs ONCOMATRYX: common questions
Which is better, Moderna or ONCOMATRYX?
On our 0-100 score Moderna rates higher (77/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Moderna and ONCOMATRYX compare on the numbers?
Moderna leads on our overall score (77/100 against 50/100), agent readiness (49/100 against 36/100), domain rating (79/100 against 26/100), headcount (6,297 against 36), funding raised ($4.5B against $107M), LinkedIn following (780,086 against 5,170).
Read the full Moderna review and pricing or the ONCOMATRYX review and pricing. You can also browse other Moderna alternatives we track.